Adenosine A2B-R Activators

Adenosine A2B-R activators includes compounds that can directly activate the ADORA2B receptor or modulate its activity through various signaling pathways. Direct activators such as NECA and BAY 60-6583 bind specifically to the receptor, mimicking adenosine's natural action and stimulating ADORA2B-mediated signaling. These compounds are crucial for understanding the receptor's role in physiological processes. Indirect activators or modulators of ADORA2B include compounds that influence the receptor's signaling environment. For instance, agents like Forskolin and IBMX, which elevate intracellular cAMP levels, can enhance ADORA2B's signal transduction. Similarly, phosphodiesterase inhibitors like Rolipram and Papaverine indirectly augment ADORA2B signaling by increasing cAMP levels. Antagonists of other adenosine receptors, such as CGS 21680 (A2A selective) and SCH 442416, also play a role in modulating ADORA2B activity through receptor cross-talk and signaling pathway interactions. Moreover, compounds like Theophylline and Caffeine, known for their antagonistic effects on adenosine receptors, can have complex actions that may include low-affinity agonism at ADORA2B. Dipyridamole, by inhibiting adenosine uptake, indirectly increases extracellular adenosine availability, enhancing ADORA2B activation.